Uterine malignant mixed mullerian tumors should not be included in studies of endometrial carcinoma
- 30 November 2006
- journal article
- Published by Elsevier BV in Gynecologic Oncology
- Vol. 103 (2), 684-687
- https://doi.org/10.1016/j.ygyno.2006.05.009
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Randomized Phase III Trial of Whole-Abdominal Irradiation Versus Doxorubicin and Cisplatin Chemotherapy in Advanced Endometrial Carcinoma: A Gynecologic Oncology Group StudyJournal of Clinical Oncology, 2006
- Endometrial carcinosarcomas have a different prognosis and pattern of spread compared to high-risk epithelial endometrial cancerGynecologic Oncology, 2005
- A pilot trial of TAC (paclitaxel, doxorubicin, and carboplatin) chemotherapy with filgastrim (r-metHuG-CSF) support followed by radiotherapy in patients with “high-risk” endometrial cancerGynecologic Oncology, 2005
- Uterine carcinosarcomas (malignant mixed Mullerian tumors) are metaplastic carcinomasInternational Journal of Gynecologic Cancer, 2002
- Paclitaxel and Platinum Chemotherapy for Malignant Mixed Mullerian Tumors of the OvaryGynecologic Oncology, 2002
- Evidence for a Common Etiology for Endometrial Carcinomas and Malignant Mixed Mullerian TumorsGynecologic Oncology, 1998
- Uterine Papillary Serous Carcinoma: Evaluation of Long-Term Survival in Surgically Staged PatientsGynecologic Oncology, 1998
- Postirradiation Sarcoma of the Gynecologic TractAmerican Journal of Clinical Oncology, 1996
- Uterine Leiomyosarcoma and Endometrial Stromal Sarcoma: Lymph Node Metastases and Sites of RecurrenceGynecologic Oncology, 1993
- Carcinosarcoma (Malignant Mixed Mesodermal Tumor) of the UterusInternational Journal of Gynecological Pathology, 1990